Affinage

GNB5

Guanine nucleotide-binding protein subunit beta-5 · UniProt O14775

Length
395 aa
Mass
43.6 kDa
Annotated
2026-06-10
23 papers in source corpus 9 papers cited in narrative 9 extracted findings
Cross-family judge vs UniProt: Affinage preferred faithfulness: 6/6 claims corpus-supported (100%)

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

GNB5 encodes Gβ5, an atypical G protein β subunit defined by five WD-40 repeats and an acidic, proline-rich N-terminal domain (PMID:7613025), that serves as an obligate partner stabilizing RGS protein complexes to terminate G protein-coupled receptor signaling (PMID:27677260, PMID:34573334). By stabilizing Gβ5–RGS complexes, it drives deactivation of D2 dopamine receptor signaling, and pathogenic variants that preserve protein expression yet abolish complex function (p.Leu307Arg) or that destabilize the protein (p.S81L) produce deficient signal termination (PMID:27677260, PMID:34573334). Loss of function in humans causes a multisystem disorder of sinus-node dysfunction (bradycardia) with neurodevelopmental and ophthalmological deficits, recapitulated in zebrafish knockouts (PMID:27523599). Mechanistically, the cardiac phenotype reflects augmented acetylcholine-activated potassium current (IK,ACh) in patient-derived cardiomyocytes, which is reversed by IK,ACh blockade (PMID:31208990), while null alleles disrupt rod and cone phototransduction recovery in the retina (PMID:31720979). Beyond canonical GPCR regulation, Gβ5 interacts directly with BACE1 through its first WD domain in a Ser81-dependent manner to negatively regulate BACE1 expression and Aβ production, with expression of the WD domain alone reducing Aβ deposition in 5xFAD mice (PMID:40587559). The N-terminal domain of Gβ5 is independently sufficient, when fused to MyoVA, to mis-target cargo in cerebellar Purkinje cells (PMID:10749990).

Mechanistic history

Synthesis pass · year-by-year structured walk · 9 steps
  1. 1995 Medium

    Establishing the protein architecture of GNB5 was the first step in defining it as a divergent member of the G protein β subunit family rather than a canonical Gβ.

    Evidence cDNA cloning and sequence analysis revealing five WD-40 repeats and an acidic proline-rich N-terminus

    PMID:7613025

    Open questions at the time
    • Does not establish a functional partner or signaling role
    • No biochemical activity demonstrated
  2. 2000 High

    The Gβ5 N-terminal domain was shown to carry cargo-targeting determinants, indicating function beyond the WD-40 core.

    Evidence Genetic and biochemical analysis of the flailer hybrid (Gnb5 N-terminus fused to MyoVA tail) in mouse Purkinje cells

    PMID:10749990

    Open questions at the time
    • The hybrid is an engineered dominant-negative; native Gβ5 cargo-trafficking role not established
    • Mechanism by which the N-terminus directs MyoVA unclear
  3. 2016 High

    Human loss-of-function genetics and a zebrafish model defined GNB5 as causative for a multisystem disorder, linking it to heart-rate control, neurodevelopment, and vision.

    Evidence Human genetic analysis of multiple families plus zebrafish gnb5 knockout phenotyping

    PMID:27523599

    Open questions at the time
    • Molecular mechanism linking loss of function to each organ phenotype not resolved in this study
    • Tissue-specific effector pathways not dissected
  4. 2016 Medium

    Connecting a specific patient variant to defective RGS stabilization tied the disorder to impaired GPCR signal termination, identifying the molecular consequence of mutation.

    Evidence Patient-derived cell assays and G protein signaling functional readouts for the p.S81L variant on D2 receptor deactivation

    PMID:27677260

    Open questions at the time
    • Single lab; reciprocal validation limited
    • Which RGS partners are most affected not delineated
  5. 2018 Low

    An overexpression study probed whether Gβ5 modulates store-operated calcium entry, proposing a STIM1-dependent, ORAI1-independent role.

    Evidence Exogenous expression with calcium imaging and dominant-negative mutant analysis

    PMID:29719456

    Open questions at the time
    • Single set of overexpression experiments without reciprocal validation
    • Endogenous relevance and physiological context not established
    • Mechanism connecting Gβ5 to STIM1 not defined
  6. 2019 High

    Isogenic patient-derived cardiomyocytes pinpointed augmented IK,ACh as the electrophysiological basis of GNB5-associated bradycardia and demonstrated pharmacological reversibility.

    Evidence CRISPR isogenic hiPSC-CM lines, patch-clamp electrophysiology, and rescue with the IK,ACh blocker XEN-R0703

    PMID:31208990

    Open questions at the time
    • In vitro cardiomyocyte model; in vivo validation of pharmacological rescue not shown
    • Link between RGS deactivation defect and IK,ACh density not fully mechanistic
  7. 2019 Medium

    ERG phenotyping of a null patient resolved the retinal defect as combined rod loss and cone recovery failure, implicating GNB5 in phototransduction termination.

    Evidence Full-field electroretinography with whole-exome confirmation of the p.Tyr344* null allele

    PMID:31720979

    Open questions at the time
    • Single patient
    • Specific RGS effector in retinal pathways not identified
  8. 2021 Medium

    A variant that preserves protein but abolishes complex function separated expression from activity, confirming that Gβ5's essential role is functional RGS-complex assembly for D2 deactivation.

    Evidence Patient fibroblast assay and BRET-based reconstitution of Gβ5S-RGS complexes with the p.Leu307Arg variant

    PMID:34573334

    Open questions at the time
    • Single lab
    • Which native RGS partner mediates the defect not specified
  9. 2025 High

    Identification of a direct Gβ5–BACE1 interaction extended Gβ5 function beyond GPCR signaling into negative regulation of amyloidogenic APP processing.

    Evidence Co-IP, AAV overexpression and conditional knockout in mice, domain-deletion and point-mutation (WD1, Ser81) analysis with Aβ deposition readout in 5xFAD mice

    PMID:40587559

    Open questions at the time
    • Structural basis of the WD1–BACE1 contact not resolved
    • Mechanism by which Gβ5 lowers BACE1 expression unclear
    • Relationship between this role and RGS-complex function not integrated

Open questions

Synthesis pass · forward-looking unresolved questions
  • How a single Gβ5 protein coordinates RGS-mediated GPCR deactivation, BACE1 regulation, and N-terminal cargo determinants within and across tissues remains unresolved.
  • No unified structural model linking the WD-40 core, N-terminus, and partner interfaces
  • Tissue-specific effector logic for cardiac vs retinal vs neuronal phenotypes not mapped

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0060089 molecular transducer activity 2 GO:0098772 molecular function regulator activity 2 GO:0005198 structural molecule activity 1
Pathway
R-HSA-162582 Signal Transduction 2
Partners
BACE1MYO5ARGS
Complex memberships
Gβ5-RGS complex

Evidence

Reading pass · 9 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
1995 GNB5 (Gnb5) encodes a protein with five WD-40 repeat units (beta-transducin motif) following an acidic N-terminal proline-rich domain, establishing it as a beta-transducin homolog and member of the G protein beta subunit family. cDNA cloning, sequence analysis, Northern/Southern hybridization Mammalian genome Medium 7613025
2000 The flailer hybrid protein combines the N-terminal 83 amino acids of Gnb5 with the C-terminal globular tail of MyoVA; this dominant-negative protein competes with wild-type MyoVA and prevents localization of smooth endoplasmic reticulum vesicles to dendritic spines of cerebellar Purkinje cells, establishing the N-terminal Gnb5 domain as sufficient to mis-target MyoVA cargo. Genetic analysis, biochemical fractionation, exon-shuffling characterization in mouse neurological mutant Human molecular genetics High 10749990
2016 Loss-of-function mutations in GNB5 cause sinus-node dysfunction (bradycardia) and neurodevelopmental deficits; zebrafish gnb5 knockouts recapitulate cardiac, neurological, and ophthalmological abnormalities, establishing a direct role for GNB5 in heart-rate control, hypotonia, and vision. Zebrafish knockout, human genetic analysis American journal of human genetics High 27523599
2016 The GNB5 p.S81L missense variant impairs protein expression and reduces the ability of Gβ5 to stabilize RGS complexes, resulting in deficient termination of dopamine receptor (D2) signaling. Patient-derived cell assays, protein expression analysis, G protein signaling functional assay Genome biology Medium 27677260
2018 GNB5 (Gβ5) overexpression enhances store-operated calcium entry (SOCE); this effect is STIM1-dependent (requires STIM1-ERM domain) and ORAI1-independent (ORAI1 loss-of-function mutant did not inhibit Gβ5-induced SOCE). Exogenous expression in cells, calcium imaging, dominant-negative mutant analysis The Korean journal of physiology & pharmacology Low 29719456
2019 The GNB5 p.S81L variant augments acetylcholine-activated potassium current (IK,ACh) in cardiomyocytes differentiated from patient-derived hiPSCs; homozygous p.S81L hiPSC-CMs showed increased IK,ACh density and more pronounced reduction of spontaneous beating upon carbachol stimulation compared to wild-type, and the IK,ACh blocker XEN-R0703 nearly reversed the bradycardia phenotype. CRISPR/Cas9 isogenic hiPSC lines, electrophysiology (patch clamp), pharmacological rescue Disease models & mechanisms High 31208990
2019 GNB5 loss-of-function (homozygous null p.Tyr344*) causes a dual retinal signaling defect: absent rod photoreceptor responses and a cone phototransduction recovery deficit, consistent with disrupted ON-bipolar and rod signaling pathways. Full-field electroretinography (extended protocol) with genetic confirmation by whole-exome sequencing Documenta ophthalmologica Medium 31720979
2021 A GNB5 missense variant (p.Leu307Arg) preserves GNB5S protein expression in patient fibroblasts but abolishes function of reconstituted Gβ5S-RGS complexes in deactivating D2 dopamine receptor activity, as measured by bioluminescence resonance energy transfer (BRET) assay. Patient-derived fibroblast assay, BRET-based functional assay with reconstituted Gβ5S-RGS complexes Genes Medium 34573334
2025 Gnb5 interacts directly with BACE1 (the rate-limiting enzyme for Aβ generation from APP) and negatively regulates BACE1 expression and Aβ production; the first WD domain of Gnb5 and the Ser81 residue are required for this regulation, as expression of the WD domain alone reduces Aβ deposition in 5xFAD mice, while the S81L point mutation abolishes this effect. Co-immunoprecipitation, AAV-mediated overexpression/conditional knockout in mice, domain-deletion and point-mutation analysis, Aβ deposition quantification PLoS biology High 40587559

Source papers

Stage 0 corpus · 23 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2016 GNB5 Mutations Cause an Autosomal-Recessive Multisystem Syndrome with Sinus Bradycardia and Cognitive Disability. American journal of human genetics 56 27523599
2002 Monosialyl-Gb5 organized with cSrc and FAK in GEM of human breast carcinoma MCF-7 cells defines their invasive properties. FEBS letters 44 12401210
2016 GNB5 mutation causes a novel neuropsychiatric disorder featuring attention deficit hyperactivity disorder, severely impaired language development and normal cognition. Genome biology 38 27677260
2007 Clustering of monosialyl-Gb5 initiates downstream signalling events leading to invasion of MCF-7 breast cancer cells. The Biochemical journal 25 16995838
2000 The mouse neurological mutant flailer expresses a novel hybrid gene derived by exon shuffling between Gnb5 and Myo5a. Human molecular genetics 24 10749990
2019 Genetic variation in GNB5 causes bradycardia by augmenting the cholinergic response via increased acetylcholine-activated potassium current (IK,ACh). Disease models & mechanisms 22 31208990
2023 Anti-Inflammatory Effects of Allocryptopine via the Target on the CX3CL1-CX3CR1 axis/GNB5/AKT/NF-κB/Apoptosis in Dextran Sulfate-Induced Mice. Biomedicines 15 36831001
2019 The epileptology of GNB5 encephalopathy. Epilepsia 15 31631344
2019 Unique retinal signaling defect in GNB5-related disease. Documenta ophthalmologica. Advances in ophthalmology 12 31720979
2018 A NGS-Targeted Autism/ID Panel Reveals Compound Heterozygous GNB5 Variants in a Novel Patient. Frontiers in genetics 12 30631341
2020 Severe Phenotype in a Patient With Homozygous 15q21.2 Microdeletion Involving BCL2L10, GNB5, and MYO5C Genes, Resembling Infantile Developmental Disorder With Cardiac Arrhythmias (IDDCA). Frontiers in genetics 8 32477400
2024 The association of GNB5 with Alzheimer disease revealed by genomic analysis restricted to variants impacting gene function. American journal of human genetics 7 38354736
2024 ITGB4/GNB5 axis promotes M2 macrophage reprogramming in NSCLC metastasis. International immunopharmacology 5 39577216
2020 IDDCA syndrome in a Chinese infant due to GNB5 biallelic mutations. Journal of human genetics 4 32203251
2021 Extended Phenotyping and Functional Validation Facilitate Diagnosis of a Complex Patient Harboring Genetic Variants in MCCC1 and GNB5 Causing Overlapping Phenotypes. Genes 3 34573334
2020 [Intellectual developmental disorder with cardiac arrhythmia syndrome in a family caused by GNB5 variation and literature review]. Zhonghua er ke za zhi = Chinese journal of pediatrics 2 32987464
2019 Generation of the induced human pluripotent stem cell lines CSSi009-A from a patient with a GNB5 pathogenic variant, and CSSi010-A from a CRISPR/Cas9 engineered GNB5 knock-out human cell line. Stem cell research 2 31479876
2018 Increased store-operated Ca2+ entry mediated by GNB5 and STIM1. The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology 2 29719456
1995 The Gnb5 gene is a novel beta-transducin homolog transcribed from a divergent promoter located immediately upstream of the Syrian hamster p53 P1 promoter. Mammalian genome : official journal of the International Mammalian Genome Society 2 7613025
2025 Mixed Segmental Uniparental Disomy of Chromosome 15q11-q1 Coexists with Homozygous Variant in GNB5 Gene in Child with Prader-Willi and Lodder-Merla Syndrome. Genes 1 40565581
2025 Gnb5 is a negative regulator of the BACE1-mediated Aβ generation and ameliorates cognitive deficits in a mouse model of Alzheimer's disease. PLoS biology 0 40587559
2025 GB5, a synergistic phytotherapy for type 2 diabetes mellitus management: an integrated polyherbal approach from phytochemical profiling to network pharmacology. BMC complementary medicine and therapies 0 41382285
2023 Inheritance of c.628-6G>A GNB5 hypomorphic allele uncovers another challenge in the pathogenic prediction of genomic variants. Clinical genetics 0 37994112

Missed literature

Know a paper Affinage missed for GNB5? Flag it for the maintainers and the community.

No submissions yet.